株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の家畜医療市場:製品別、診断技術別、動物別、地域別 - 動向および予測

Farm Animal Healthcare Market by Products (vaccines, paraciticides, anti-infectives, medicinal feed additives, and other pharmaceuticals), By diagnostic technologies, by Animal Typ

発行 Mordor Intelligence LLP 商品コード 319395
出版日 ページ情報 英文 190 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界の家畜医療市場:製品別、診断技術別、動物別、地域別 - 動向および予測 Farm Animal Healthcare Market by Products (vaccines, paraciticides, anti-infectives, medicinal feed additives, and other pharmaceuticals), By diagnostic technologies, by Animal Typ
出版日: 2016年08月01日 ページ情報: 英文 190 Pages
概要

世界の家畜医療市場は、2014年に134億6,000万米ドルになると予測されています。同市場は今後もCAGR8.25%で成長しつづけ、2018年には202億米ドルに達するとみられています。

当レポートでは、世界の家畜医療市場の現状と将来予測、セグメント別、地域別動向とともに、主要な参入企業の競合環境とプロファイルなどをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品
  • 動物医療と人間医療

第3章 市場動向

  • 市場促進因子
    • ペットオーナーシップ
    • 栄養の改善
    • 消費者が食品の安全性への注意を高めている
    • 飼料の増産
    • 動物原性感染病および食物経由の疾患
  • 市場阻害因子
    • 耕作地と水の危機
    • 耕作地の競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 市場セグメンテーション

  • 製品別
    • 寄生虫駆除剤
    • 抗炎症薬
    • 医療用食品添加物
    • その他の医薬品
    • ワクチン
  • 家畜

第5章 世界の家畜診断薬市場

  • 酵素結合免疫吸着検査法
  • 即時免疫移動
  • 寒天ゲル免疫核酸法

第6章 世界の家畜遺伝学市場

第7章 地域別市場セグメンテーション

  • 北米
  • 欧州
  • アジア太平洋地域

第8章 競合環境

  • 市場における主要企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、パートナーシップ

第9章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第10章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Cattle producers have long recognized the need for proper husbandry and stewardship, given the intensive animal husbandry model that currently houses a majority of cattle reared each year. Growing beef production and increasing demand for animal protein in an era of ever stricter regulations for rearing and food safety testing will have a positive impact on the cattle healthcare market. Health consciousness is an increasing concern and as Americans attempt to eat healthier food, producers respond and new products are appearing in the marketplace - and beef is no exception.

Statistics shows that in 2013, global cattle population was estimated to be 1485.2 million and with increasing awareness for cattle healthcare, number is expected to increase further which in turn will propel cattle healthcare market to grow.

In a country wise analysis it is seen that emerging markets such as Eastern Europe, Latin America and Asia are witnessing an increase in share because of the increasing importance given to animal health by the livestock breeders. As these regions are showing very strong economic growth in recent past years, livestock breeders are giving due importance to management of cattle health to cater to the growing nutritional needs of population. In developed countries market will be stagnant in coming years because of less consumption of cattle meat and dairy products.

Major company players are looking at the entire cattle healthcare ecosystem to maximize value for farmers. Creating value in addition to the products and services that firms offer has been a key strategy. The E=P+S program, for instance, helps farmers become profitable while keeping their operations sustainable given more discriminating preferences of end-consumers.

In this report, the market is segmented by type of disease into vaccines, Paraciticides, Anti-Infectives; Medicinal feed additives, and other pharmaceuticals. The market is further segmented by diagnostics -Enzyme Linked Sorbent Assay (ELISA), Rapid Immuno migration (RIM), and Agar Gel Immuno diffusion (AGID), and genetics. Regional markets analyzed in this report are North America, Europe, Asia-Pacific and the rest of the world (Row).

What the report offers

  • 1) Market definition for Global cattle healthcare with information on drivers and restraints.
  • 2) Market Analysis involving Cattle healthcare products available in market, relation between animal medicines and human medicines.
  • 3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
  • 4) Extensively researched competitive landscape with profiles of major companies along with their market share.
  • 5) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Reasons for buying this report

  • 1) We provide you the longest market segmentation by type of products (vaccines, paraciticides, anti-infectives, medicinal feed additives and other pharmaceuticals), By Diagnostic market, by Genetics market and by Geography.
  • 2) Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
  • 3) Wide-ranging information provided about the leading market players, major strategies adopted by them and new products launched by them.

Management of livestock to cater to the growing nutritional needs of populations. But with various kinds of diseases reducing global animal production, animal healthcare is gaining significant importance. Emerging economies thus offer significant potential for animal health industry in the near future.

The mature markets of North America and Western Europe, however, are supporting the growth of animal health market as these regions are characterized by strong growth, particularly in the companion animals sector.

Table of Contents

1.INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Recent Trends

2. Market Analysis

  • 2.1. Market Animal Health Products
  • 2.2. Animal medicines vs human Medicines

3. Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increase in pet ownership
    • 3.1.2. Improved Nutrition
    • 3.1.3. Intensifying consumer focus on food safety
    • 3.1.4. Greater Livestock production
    • 3.1.5. Increasing Zoonotic and Foodborne Diseases
  • 3.2. Market Constraints
    • 3.2.1. Scarcity of arable land and water
    • 3.2.2. Increased competition for cultivated land
    • 3.2.3. Cost effective production
  • 3.3. Porter's Five Force Analysis
    • 3.3.1. Threat of New Entrant
    • 3.3.2. Internal Rivalry
    • 3.3.3. Buyer bargaining power
    • 3.3.4. Supplier bargaining power
    • 3.3.5. Threat of substitutes

4. Global Farm Animal Market Segmentation -By products

  • 4.1. Farm Animals
    • 4.1.1. Vaccines
    • 4.1.2. Paraciticides
    • 4.1.3. Anti-Infectives
    • 4.1.4. Medicinal Feed additives
    • 4.1.5. Other Pharmaceuticals
  • 4.2. Farm animal
    • 4.2.1Cattle
    • 4.2.2. Swine
    • 4.2.3. Poultry
    • 4.2.4. Fish
    • 4.2.5. Sheep

5. Global Farm Animal Diagnostics Market

    • 5.1.1. Enzyme Linked Immuno Sorbent Assay( ELISA)
    • 5.1.2. Rapid Immuno Migration( RIM)
    • 5.1.3. Agar gel Immuno Diffusion( AGID)

6. Global Farm Animal Genetics Market

  • 6.1. HD 50K for Angus
  • 6.2. CLARIFIDE ¨ for Dairy
  • 6.3. Sheep 50K
  • 6.4. CLARIFIDE ¨ for Nelore
  • 6.5. Others

7.Global Farm Animal Market Segmentation, By Geography

  • 7.1. North America
    • 7.1.1. US
    • 7.1.2. Mexico
    • 7.1.3Canada
  • 7.2. Europe
    • 7.2.1. France
    • 7.2.2. Italy
    • 7.2.3. Germany
    • 7.2.4. Spain
    • 7.2.5. Italy
  • 7.3. Asia-Pacific
    • 7.3.1India
    • 7.3.2. China
    • 7.3.3. Japan

8. Competitive landscape

  • 8.1. Major players in the market
  • 8.2. Mergers and acquisitions
  • 8.3. New product launches
  • 8.4. Agreement, Collaborations and Partnerships
  • 8.5. Recommendations for New market players
  • 8.6. Recommendations for Existing market players
  • 8.7. Market Share Analysis

9.Company profiles

  • 9.1. Zoetis animal healthcare
    • 9.1.1. Financial Overview
    • 9.1.2. Business overview
    • 9.1.3. Business strategies
  • 9.2. Merck
    • 9.2.1Financial Overview
    • 9.2.2. Business overview
    • 9.2.3. Business strategies
  • 9.3. Merial (Animal Health Division Of Sanofi)
    • 9.3.1. Financial Overview
    • 9.3.2. Business overview
    • 9.3.3. Business strategies
  • 9.4. Elanco
    • 9.4.1. Financial Overview
    • 9.4.2. Business overview
    • 9.4.3. Business strategies
  • 9.5. Bayer healthcare
    • 9.5.1. Financial Overview
    • 9.5.2. Business overview
    • 9.5.3. Business strategies
  • 9.6. Novartis Animal Health, Inc.
    • 9.6.1. Financial Overview
    • 9.6.2. Business overview
    • 9.6.3. Business strategies
  • 9.7. Virbac
    • 9.7.1. Financial Overview
    • 9.7.2. Business overview
    • 9.7.3. Business strategies
  • 9.8. Boehringer Ingelheim
    • 9.8.1. Financial Overview
    • 9.8.2. Business overview
    • 9.8.3. Business strategies

10. Appendix

  • 10.1. Abbreviations
  • 10.2. Sources
  • 10.3. Bibliography
  • 10.4. Disclaimer
Back to Top